Status:

COMPLETED

AS-OCT Study of Cornea and Tear Film Parameters in SLE Patients

Lead Sponsor:

Minia University

Conditions:

Systemic Lupus Erythematosus

Eligibility:

All Genders

18-60 years

Brief Summary

The aim of thie study to assess tear film parameters such as tear meniscus height (TMH), tear meniscus area (TMA), and tear meniscus depth (TMD). In addition, corneal pachymetry and epithelial thickne...

Detailed Description

Systemic lupus erythematous (SLE) is a relapsing and remitting autoimmune connective tissue disorder that can affect many organs such as skin, joints, kidneys, eye, and brain (1) . SLE has a global pr...

Eligibility Criteria

Inclusion

  • Age ≥18 years old..
  • Patients with SLE diagnosed by a rheumatologist with no ocular involvement upon clinical examination

Exclusion

  • 1\. Patients with history of intraocular surgery as cataract surgery ,retinal detachment surgery, anti-glucoma surgery.
  • 2\. Patients with history of any corneal refractive surgery as LASIK, PRK. 3. Patients with significant media opacity as corneal opacity, cataract. 4. Patients with ocular diseases as glaucoma, uveitis. 5. Patients with any retinal affection as pathological myopia, macular hole, age related macular degeneration and retinal vascular occlusion.
  • 6\. Patients with systemic diseases as diabetes mellitus, hypertension, abnormal kidney function.

Key Trial Info

Start Date :

July 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 30 2021

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04873739

Start Date

July 1 2020

End Date

March 30 2021

Last Update

February 3 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Minia university hospital

Minya, Egypt